National Institute of Allergy and Infectious Diseases Director Anthony Fauci said that the messaging around Johnson & Johnson’s one-shot COVID-19 vaccine needs to change so that underserved and disadvantaged communities don’t mistakenly perceive the vaccine, which FDA is reviewing for potential emergency use authorization, as being inferior to the FDA-authorized Pfizer and Moderna vaccines. Community leaders and health officials need to emphasize that J&J’s product is highly effective against severe disease and a value-added vaccine, Fauci said. Fauci’s comments come...